Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore exercitation ullamco…

Dr. I. Mark Landy

EVP and Chief Strategy Officer


Dr. Landy was named the Company’s Executive Vice President and Chief Strategy Officer in December 2018. He joined MiMedx in June 2016 as the Company’s Vice President of Strategic Initiatives, bringing a depth of healthcare industry and clinical expertise.

Dr. Landy’s wide array of experience includes holding senior roles in institutional healthcare equity research, Portfolio Management and C-Level executive roles in the drug delivery and medical devices sectors of the healthcare industry. He has over fifteen years of Wall Street expertise and seven years of healthcare industry experience.

Immediately prior to joining MiMedx, Dr. Landy was Director of Research, Managing Director and Senior Research Analyst – Biopharmaceuticals and Medical Technology at Northland Capital Markets / Summer Street Research Partners. Prior thereto, Dr. Landy served with MIV Therapeutics, Inc., a global leader in developing polymer-free drug delivery systems for cardiovascular stents and other implantable devices. During his time at MIV, Dr. Landy served as a Director of the company, President and Chief Executive Officer. Prior to his tenure with MIV, he held senior positions with Susquehanna Financial Group; Leerink; Merlin BioMed Capital Management; and Investor AB.

Dr. Landy holds a Bachelor of Business Administration from The Wharton School of Business, University of Pennsylvania, and a Doctor of Dental Surgery from the University of the Witwatersrand, Johannesburg, South Africa.